Mankind Pharma's AI marketing campaign starring Anushka Sharma elevates Prega News reach and impact
Mankind Pharma, a reputed global pharmaceutical company, recently unveiled its groundbreaking AI-powered marketing campaign, featuring popular Bollywood actress, Anushka Sharma, as the face of their trusted pregnancy detection brand, Prega News. The innovative campaign aims to revolutionize the way the brand reaches its audience and reinforces Prega News' reputation as a reliable choice for pregnancy testing.
The primary focus of this campaign is to target pharmacies and essential retail partners who significantly contribute to boosting the visibility and sales of pregnancy detection kits among consumers. Leveraging the power of AI, Mankind Pharma endeavours to create a personalized connection with lakhs of pharma outlets across the country.
The foundation of the campaign is the utilization of an AI-driven digital avatar of Anushka Sharma, who exclusively endorses individual pharmacies. Through this personalized approach, Mankind Pharma ensures that each outlet receives a personalized advertisement via WhatsApp. This personalized touch fosters a strong bond between the brand, the pharmacy, and its customers, amplifying the reach of Prega News among its audience.
Additionally, Mankind Pharma executes localized YouTube video ads for pharmacies by using their PIN code to ensure that customers were directed to the nearest shop to purchase Prega News. This strategic move aims to enhance business visibility and popularity for individual outlets. The overwhelmingly positive response from the pharmacies exceeded expectations, reinforcing Mankind Pharma's commitment to employing cutting-edge technology in their marketing endeavours.
Joy Chatterjee, Associate Vice President, Sales & Marketing, Mankind Consumer Healthcare Division said, "We are immensely proud of the success of our landmark AI campaign for Prega News. This innovative initiative has not only strengthened our bond with our valued retail partners but has also enabled us to touch the lives of countless consumers across the nation. At Mankind Pharma, we remain committed to leveraging cutting-edge technology to drive positive change in the healthcare industry and empower our customers with trusted solutions."
The AI-driven campaign engages pharmacies and extends their reach to their customers, friends, and family through social sharing. By encouraging pharmacies to share personalized ads, the campaign expands its reach, resulting in significant brand awareness.
As the pharmaceutical industry continues to embrace advancements in AI technology, Mankind Pharma remains at the forefront, constantly striving to deliver innovative solutions that empower their partners and benefit the lives of consumers.
About Mankind Pharma
Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices.
The company is a leading player in the domestic pharmaceuticals business present across acute and chronic therapeutic areas. This includes products for anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, VMN and respiratory diseases, among others with a strategy to increase market presence/ share for chronic ailments. In the consumer healthcare business, the company operates in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories, among others, with several category-leading brands. The company has 25 manufacturing facilities across India and has over four thousand manufacturing personnel as of December 31, 2022. Manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products.
Mankind has a consistent track record of product innovation, as of December 31, 2022, Company had a team of over 600 scientists and a dedicated in-house R&D center with four units located in IMT Manesar, Gurugram, Haryana and Thane, Maharashtra.
Reach out to us at PR Desk
Get rewarded for your reading habits on the Dais World app!